Bristol-Myers Squibb Is A Speculative Buy On Price Action (Technical Analysis)
Bristol-Myers Squibb(US:BMY) Seeking Alpha·2024-04-02 00:58monsitj Bristol-Myers Squibb, Inc. (NYSE:BMY) is in the health care sector and in the pharmaceutical industry. While not a factor in my analysis of the company, BMY is expected to have 2024 annual revenue of $45.85B and annual earnings per share of $6.83. BMY is also yielding a safe 4.43%. In this article I will outline why I think BMY is a speculative buy at this price. It is speculative because not all of my preferred parameters are in place yet as I will outline in the article. My investment thesis w ...